In vitro evaluation of anti-pathogenic surface coating nanofluid, obtained by combining Fe3O4/ C12 nanostructures and 2-((4-ethylphenoxy) methyl)-N-(substituted-phenylcarbamothioyl)- benzamides

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages 1-10

  Anghel, Ion ^a   Limban, Carmen ^a   Grumezescu, Alexandru Mihai ^b   Anghel, Alina Georgiana ^a   Bleotu, Coralia ^c   Chifiriuc, Mariana Carmen ^d  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^c STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

^d UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Anti biofilm; Benzamides; Core shell nanostructure; Lauric acid; Magnetite; Thiourea derivatives

Indexed keywords

BACTERIA; BIOCOMPATIBILITY; BIOFILMS; COATINGS; IRON OXIDES; MAGNETITE; NANOSTRUCTURES; SCANNING ELECTRON MICROSCOPY;

ANTI-BIOFILM; BENZAMIDES; CORE/SHELL; LAURIC ACID; THIOUREA DERIVATIVES;

NANOFLUIDICS;

EID: 84871023380     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-513     Document Type: Article

References (47)

1. Anghel I, Chifiriuc MC, Mitache M, Marutescu L, Anghel AG, Popa M, Pelinescu D, Bleotu C, Lazar V: Phenotypic and genotypic assessment of virulence factors in betahemolytic streptococci isolated from kindergarten infantile population, with or without clinical symptoms, including scarlet fever. Farmacia 2012, 60:21-31.
2. Kumar N, Shalini K, Drabu S: Synthesis and pharmacological screening of various new quinazolin-4-one derivatives as anti-inflammatory and antifungal agents. Biointerface Res Appl Chem 2011, 1:203-208.
3. Shalini K, Kumar N, Sharma PK: Synthesis of N-(2-substituted phenyl)-4, 5-diphenyl-1 H-imidazol-1yl)(phenyl)methyl) substituted amine derivatives, spectral characterization and their pharmacological evaluation. Biointerface Res Appl Chem 2011, 1:184-190.
4. Prasad SK, Kumar SL, Prasad M, Jayalakshmi B, Revanasiddappa HD: Synthesis, spectral characterization, DNA interaction studies, anthelmintic and antimicrobial activity of transition metal complexes with 3-(2-hydroxybenzylideneamino)-2-methylquinazolin-4(3 H)-one and 1,10-phenanthroline. Biointerface Res Appl Chem 2011, 1:127-138.
5. Sarmah KN, Sarmah NK, Patel TV, Kurmi KB: Synthesis, characterization, antimicrobial studies of certain triazole containing s-triazine derived compound. Int J Comput Eng Res 2012, 2:289-293.
6. Sarmah KN, Patel TV: Synthesis, characterization, antimicrobial studies of certain s-triazine derived compounds and analogues. Arch Appl Sci Res 2011, 3:428-436.
7. Kurt G, Sevgi F, Mercimek B: Synthesis, characterization, and antimicrobial activity of new benzoylthiourea ligands. Chem Pap 2009, 63:548-553.
8. Saeed A, Rafique H, Hameed A, Rasheed S: Synthesis and antibacterial activity of some new 1-aroyl-3-(substituted-2-benzothiazolyl)-thioureas. Pharm Chem J 2008, 42:191-195.
9. Abdel-Rahman HM, Morsy MA: Novel benzothiazolyl urea and thiourea derivatives with potential cytotoxic and antimicrobial activities. J Enzyme Inhib Med Chem 2007, 22:57-64.
10. Cunha S, Macedo FC Jr, Costa GAN, Rodrigues MTJ, Verde RBV, de Souza Neta LC, Vencato I, Lariucci C, Sa FP: Antimicrobial activity and structural study of disubstituted thiourea derivatives. Monatsh Chem Chem Mon 2007, 138:511-516.
11. Tokuyama R, Takahashi Y, Tomita Y, Tsubouchi M, Yoshida T, Iwasaki N, Kado N, Okezaki E, Nagata O: Structure-activity relationship (SAR) studies on oxazolidinone antibacterial agents. 2. Relationship between lipophilicity and antibacterial activity in 5-thiocarbonyl oxazolidinones. Chem Pharm Bull 2001, 49:353-360.
12. Hellmann M, Mehta SD, Bishai DM, Mears SC, Zenilman JM: The estimated magnitude and direct hospital costs of prosthetic joint infections in the United States, 1997 to 2004. J Athroplasty 2010, 25:766-771.
13. Tokarczyk AJ, Greenberg SB, Vender JS: Death, dollars, and diligence: prevention of catheter-related bloodstream infections must persist. Crit Care Med 2009, 37:2320-2321.
14. Anghel I, Chifiriuc MC, Anghel GA: Pathogenic features and therapeutical implications of biofilm development ability in microbial strains isolated from rhinologic chronic infections. Farmacia 2011, 59:770-783.
15. Knetsch MLW, Koole LH: New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymers 2011, 3:340-366.
16. Jun Sung K, Eunye K, Kyeong Nam Y, Jong-Ho K, Sung Jin P, Hu Jang L, So Hyun K, Young Kyung P, Yong Ho P, Cheol-Yong H, Yong-Kwon K, Yoon-Sik L, Dae Hong J, Myung-Haing C: Antimicrobial effects of silver nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine 2007, 3:95-101.
17. Rai A, Prabhune A, Perry CC: Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J Mater Chem 2010, 20:6789-679.
18. Gajjar P, Pettee B, Britt DW, Huang W, Johnson WP, Anderson AJ: Antimicrobial activities of commercial nanoparticles against an environmental soil microbe, Pseudomonas putida KT2440. J Biol Eng 2009, 3:9.
19. Subhasree RS, Selvakumar D, Kumar NS: Hydrothermal mediated synthesis of ZnO nanorods and their antibacterial properties. Lett Appl NanoBioSci 2012, 1:2-7.
20. Andronescu E, Grumezescu AM, Ficai A, Gheorghe I, Chifiriuc M, Mihaiescu DE, Lazar V: In vitro of antibiotic magnetic dextran microspheres complexes against Staphylococcus aureus and Pseudomonas aeruginosa strains. Biointerface Res Appl Chem 2012, 2:332-338.
21. Baier J, Strumberger R, Berger F, Atanasova P, Welzel U, Bill J: Mineralization and particle growth kinetics of ZnO in the presence of gelatin. Biointerface Res Appl Chem 2012, 2:339-349.
22. Marquez MF, Herrera GM, Campo T, Cotto MC, Duconge J, Sanz JM, Elizalde E, Perales O, Morant C: Preparation of hollow magnetite microspheres and their applications as drugs carriers. Nanoscale Res Lett 2012, 7:210.
23. Labouta IH, Schneider M: Tailor-made biofunctionalized nanoparticles using layer-by-layer technology. Int J Pharm 2010, 395:236.
24. Mantle MD: Quantitative magnetic resonance micro-imaging methods for pharmaceutical research. Int J Pharm 2011, 417:173.
25. Karmali RJ, Bartakke A, Borker VP, Rane KS: Bactericidal action of N doped ZnO in sunlight. Biointerface Res Appl Chem 2011, 1:57-63.
26. Mihaiescu DE, Horja M, Gheorghe I, Ficai A, Grumezescu AM, Bleotu C, Chifiriuc MC: Water soluble magnetite nanoparticles for antimicrobial drugs delivery. Lett Apll NanoBioSci 2012, 1:45-49.
27. Chifiriuc MC, Lazar V, Bleotu C, Calugarescu I, Grumezescu AM, Mihaiescu DE, Mogoşanu DE, Buteica AS, Buteica E: Bacterial adherence to the cellular respectively inert substrate in the presence of magnetic CoFe2O4 and Fe3O4/oleic acid-core/shell nanoparticle. Digest J Nanomat Biostr 2011, 6:37-42.
28. Saviuc C, Grumezescu AM, Holban A, Chifiriuc C, Mihaiescu D, Lazar V: Hybrid nanostructurated material for biomedical applications. Biointerface Res Appl Chem 2011, 1:64-71.
29. Saviuc C, Grumezescu AM, Holban A, Bleotu C, Chifiriuc C, Balaure P, Lazar V: Phenotypical studies of raw and nanosystem embedded Eugenia carryophyllata buds essential oil antibacterial activity on Pseudomonas aeruginosa and Staphylococcus aureus strains. Biointerface Res Appl Chem 2011, 1:111-118.
30. Wang H, Wang S, Liao Z, Zhao P, Su W, Niu R, Chang J: Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging. Int J Pharm 2011, 430:343.
31. Schweiger C, Pietzonka C, Heverhagen J, Kissel T: Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging. Int J Pharm 2011, 408:130-137.
32. Chifiriuc MC, Grumezescu AM, Saviuc C, Croitoru C, Mihaiescu DE, Lazar V: Improved antibacterial activity of cephaloporins loaded in magnetic chitosan microspheres. Int J Pharm 2012. doi:10.1016/j.ijpharm.2012.06.031.
33. Mihaiescu DE, Grumezescu AM, Balaure PC, Mogosanu DE, Traistaru V: Magnetic scaffold for drug targeting: evaluation of cephalosporins controlled release profile. Biointerface Res Appl Chem 2011, 1:191-195.
34. Akbarzadeh A, Samiei M, Davaran S: Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett 2012, 7:144.
35. Medeiros SF, Santos AM, Fessi H, Elaissari A: Stimuli-responsive magnetic particles for biomedical applications. Int J Pharm 2011, 403:139.
36. Chifiriuc MC, Grumezescu V, Grumezescu AM, Saviuc CM, Lazar V, Andronescu E: Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res Lett 2012, 7:209.
37. Grumezescu AM, Saviuc C, Chifiriuc MC, Hristu R, Mihaiescu DE, Balaure P, Stanciu G, Lazar V: Inhibitory activity of Fe3O4/oleic acid/usnic acid-core/ shell/extra-shell nanofluid on S. aureus biofilm development. IEEE T. Nanobiosci 2011, 10:269-274.
38. Grumezescu AM, Andronescu E, Ficai A, Mihaiescu DE, Vasile BS, Bleotu C: Synthesis, characterization and biological evaluation of a magnetite/ lauric acid core/shell nanosystem. Lett Appl NanoBioSci 2012, 1:31-35.
39. Limban C, Missir AV, Chiriţǎ IC, Niţulescu GM, Ilie C, Cǎproiu MT: Some new 2-(4-ethyl-phenoxymethyl)benzoic acid thioureides: synthesis and spectral characterisation. Rev Chem (Bucharest) 2009, 60:657-661.
40. GraphPad Software: [www.graphpad.com].
41. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA: Guidelines for the prevention of intravascular catheterrelated infections. Morb Mortal Wkly Rep Recomm Rep 2002, 51:1-29.
42. Pfaller MA, Rempe LE, Jebson PJR, Kamal D: Reduced intravascular catheter infection by antibiotic bonding a prospective, randomized, controlled trial. MBBS, FFARCS, DEAA; FFARCS JAMA 1991, 265:2364-2368.
43. Bassetti S, Hu J, D'Agostino RB, Sherertz RJ: Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo. Antimicrob Agents Chemother 2001, 45:1535-1538.
44. Shah A, Mond J, Walsh S: Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization. Antimicrob Agents Chemother 2004, 48:2704-2707.
45. Soboh F, Khoury AE, Zamboni AC, Davidson D, Mittelman MW: Effects of ciprofloxacin and protamine sulfate combinations against catheterassociated Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 1995, 39:1281-1286.
46. Kaplan JB: Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses. JDR 2010, 89(3):205-218.
47. Abd El-Baky RM: Scanning Electron Microscopy. In Application of scanning electron microscopy for the morphological study of biofilm in medical devices. Edited by Viacheslav K. Rijeka: InTech; 2012.